Genomics x AI: Reading Biology at Scale

​Sequencing is breaking new ground in speed, scale and insights. Long reads, native methylation and cell-free DNA now capture layers of biology that were invisible a decade ago, and AI is turning that data into diagnostics, foundation models and new ways to understand disease. Join founders, builders and investors for an evening on where genomics x AI goes next.

​Speakers (more to be announced)

• ​Gordon Sanghera, Founder and former CEO of Oxford Nanopore Technologies, on how long-read sequencing went from lab curiosity to a platform reshaping clinical genomics

• ​Joining him: the founders building what comes after sequencing. Names revealed soon.

​Followed by drinks and networking.

​Co-hosted by Wilbe Labs, Ananda, Daphni and Heal Capital.

​About WilbeLABS

​WilbeLABS provides ready-to-use labs and workspaces for scientist-led companies. We’re part of Wilbe, a home for scientists building companies, from their first investment cheque to the space they need to grow.